Patents by Inventor Lianying Zhang

Lianying Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11332707
    Abstract: An endophytic fungus from gingko, that is, Fusarium proliferatum DZHQ1 having antitumor activity and antibacterial activity, is isolated from the ginkgo bark. The species of the strain is determined by the combination of colonial morphology and 18 sRNA sequencing, and then the anti-cervical cancer activity of a crude extract of the strain is detected by MTT. Finally, a secondary metabolite of the strain with an inhibition rate of more than 50% is isolated by semi-preparative HPLC, which promotes the further screening of individual compounds with anti-tumor activity. Moreover, the metabolite of the endophytic fungus from gingko shows a more pronounced inhibition in the detection of activity against E. coli and/or S. aureus, and has potential use in the preparation of new antibacterial products.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: May 17, 2022
    Assignee: DEZHOU UNIVERSITY
    Inventors: Qing He, Qiangcheng Zeng, Lianying Zhang, Zhongmin Dai, Haixia Zhou, Mingyou Wang, Jianzhou Meng
  • Publication number: 20210238538
    Abstract: An endophytic fungus from gingko, that is, Fusarium proliferatum DZHQ1 having antitumor activity and antibacterial activity, is isolated from the ginkgo bark. The species of the strain is determined by the combination of colonial morphology and 18 sRNA sequencing, and then the anti-cervical cancer activity of a crude extract of the strain is detected by MTT. Finally, a secondary metabolite of the strain with an inhibition rate of more than 50% is isolated by semi-preparative HPLC, which promotes the further screening of individual compounds with anti-tumor activity. Moreover, the metabolite of the endophytic fungus from gingko shows a more pronounced inhibition in the detection of activity against E. coli and/or S. aureus, and has potential use in the preparation of new antibacterial products.
    Type: Application
    Filed: November 2, 2018
    Publication date: August 5, 2021
    Applicant: DEZHOU UNIVERSITY
    Inventors: Qing HE, Qiangcheng ZENG, Lianying ZHANG, Zhongmin DAI, Haixia ZHOU, Mingyou WANG, Jianzhou MENG
  • Patent number: 6287724
    Abstract: A metal hydride rechargeable cell is provided that discharges during a test discharge at a rate of 8 C to 18 C and a cell temperature of 0° C. where the voltage remains above 0.2 volts during the half of the discharge curve. The cell comprises a negative electrode of hydrogen storage alloy material having a particle size volume distribution whose d(50) value does not exceed 2(2Dht)½, where Dh is the hydrogen diffusion coefficient for the alloy at 0° C. and t is a time period from about 200 to about 450 seconds. A method of manufacturing the cell of the present invention involves an activation protocol comprising at least one formation cycle, a heat treating step, and a cycling step. This method avoids unnecessary processing of the metal alloy material prior to incorporation into the negative electrode.
    Type: Grant
    Filed: July 17, 1998
    Date of Patent: September 11, 2001
    Assignee: Eveready Battery Company, Inc.
    Inventors: Deepika B. Singh, Lianying Zhang, Michael R. Klein, Vince Puglisi, Thomas R. DeMoully, Jai Prakash